Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly

Vaccine

Volumn 28, Issue 38, 2010, Pages 6159-6163

  Kao, Tsui Mai ^a   Hsieh, Szu Min ^a   Kung, Hsiang Chi ^a   Lee, Yi Chien ^a   Huang, Kuo Chin ^a   Huang, Li Min ^a   Chang, Feng Yee ^b   Wang, Ning Chi ^b   Liu, Yung Ching ^c   Lee, Wen Sen ^d   Liu, Hsingjin Eugene ^d   Chen, Chin I ^d   Chen, Chien Hui ^e  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e Taiwan Product Quality Research Institute   (Taiwan)

Author keywords

2009 Pandemic influenza A (H1N1); Immune response; Vaccination

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ;

AGED; ANTIBODY TITER; ARTICLE; BODY MASS; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; FEMALE; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PANDEMIC; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; TAIWAN;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ANTIBODY FORMATION; DIABETES MELLITUS; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SEX FACTORS; SINGLE-BLIND METHOD; TAIWAN;

EID: 77955661281     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.07.026     Document Type: Article

References (23)

1. Update: swine influenza A/H1N1 infections - California and Texas, April 2009. MMWR Morb Mortal Wkly Rep 2009, 58:435-437.
2. Swine influenza A/H1N1 infection in two children - Southern California, March - April 2009. MMWR Morb Mortal Wkly Rep 2009, 58:400-402.
3. New influenza A/H1N1 virus: global epidemiological situation, June 2009. Wkly Epidemiol Rec 2009, 84:249-257.
4. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361:1945-1952.
5. Greeberg M.E., Lai M.H., Hartel G.F., Wichems C.H., Gittleson C., Bennet J., et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009, 361:2405-2413.
6. Brydak L.B., Machała M., Myśliwska J., Myśliwski A., Trzonkowski P. Immune response to influenza vaccination in an elderly population. J Clin Immunol 2003, 23:214-222.
7. McElhaney J.E., Dutz J.P. Better influenza vaccines for older people: what will it take?. J Infect Dis 2008, 198:632-634.
8. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24:1159-1169.
9. World Health Organization. Availability of a candidate reassortant vaccine virus for the novel influenza A (H1N1) vaccine development X-179A. (Accessed Jan. 19, 2010, at ). http://www.who.int/csr/resources/publications/swineflu/candidatesX-179a/en/.
10. European Committee for Proprietary Medicinal Products Note for guidance on harmonisation of requirements for influenza vaccines (CPMP/BWP/214/96) 1997, The European Agency for the Evaluation of Medicinal Products, London.
11. Center for Biologics Evaluation and Research Guidance for industry: clinical data needed to support the licensure of pandemic influenza vaccines 2007, Food and Drug Administration, Bethesda, MD.
12. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009, 58:521-524.
13. Zhu F.C., Wang H., Fang H.H., Yang J.G., Lin X.J., Liang X.F., et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 2009, 361:2414-2423.
14. Sambhara S., McElhaney J.E. Immunosenescence and influenza vaccine efficacy. Curr Top Microbiol Immunol 2009, 333:413-429.
15. Hui S.L., Chu L.W., Peiris J.S., Chan K.H., Chu D., Tsui W., et al. Immune response to influenza vaccination in community-dwelling Chinese elderly persons. Vaccine 2006, 24:5371-5380.
16. Whitacre C.C., Reingold S.C., O'Looney P.A. A gender gap in autoimmunity. Science 1999, 283:1277-1278.
17. Rider V., Abdou N.I. Sexual dimorphism and the immune system in principles of gender-specific medicine 2004, 1071-1081. Elsevier Academic Press, London. M.J. Legato (Ed.).
18. Cook I.F. Sexual dimorphism of humoral immunity with human vaccines. Vaccine 2008, 26:3551-3555.
19. Bouter K.P., Diepersloot R.J., Wismans P.J., Gmelig Meyling F.H., Hoekstra J.B., Heijtink R.A., et al. Humoral immune response to a yeast-derived hepatitis B vaccine in patients with type 1 diabetes mellitus. Diabet Med 1992, 9:66-69.
20. Marseglia G., Alibrandi A., d'Annunzio G., Gulminetti R., Avanzini M.A., Marconi M., et al. Long term persistence of anti-HBs protective levels in young patients with type 1 diabetes after recombinant hepatitis B vaccine. Vaccine 2001, 19:680-683.
21. Prevention and control of influenza: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 1990, 39(RR-7):1-15.
22. Smith N.M., Bresee J.S., Shay D.K., Uyeki T.M., Cox N.J., Strikas R.A., et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006, 55(RR-10):1-42.
23. Skowronski D.M., Tweed S.A., De Serres G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?. J Infect Dis 2008, 197:490-502.